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Background: IUGR infants are thought to have impaired gut function after birth, which may result in intestinal
disturbances, ranging from temporary intolerance to the enteral feeding to full-blown NEC.
In literature there is no consensus regarding the impact of enteral feeding on intestinal blood flow and hence
regarding the best regimen and the best rate of delivering the enteral nutrition.
Methods/design: This is a randomized, non-pharmacological, single-center, cross-over study including 20 VLBW
infants.
Inclusion criteria
* Weight at birth ranging: 700–1501 grams
* Gestational age up to 25 weeks and 6 days
* Written informed consent from parents or guardians
Exclusion criteria
* Major congenital abnormality
* Patients enrolled in other trials
* Significant multi-organ failure prior to trial entry
* Pre-existing cutaneous disease not allowing the placement of the NIRS’ probe
In the first 24 hours of life, between the 48th and 72nd hours of life, and during Minimal Enteral Feeding, all infants’
intestinal perfusion will be evaluated with NIRS and a Doppler of the superior mesenteric artery will be executed.
At the achievement of an enteral intake of 100 mL/Kg/day the patients (IUGR and NON IUGR separately) will be
randomized in 2 groups: Group A (n=10) will receive a feed by bolus (in 10 minutes); then, after at least 3 hours,
they will receive the same amount of formula administered in 3 hours. Group B (n=10) will receive a feed* Correspondence: vbozzetti@hotmail.com
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least 3 hours.
On the randomization day intestinal and cerebral regional oximetry will be measured via NIRS. Intestinal and
celebral oximetry will be measured before the feed and 30 minutes after the feed by bolus during the 3 hours
nutrition the measurements will be performed before the feed, 30 minutes from the start of the nutrition and 30
minutes after the end of the gavage. An evaluation of blood flow velocity of the superior mesenteric artery will be
performed meanwhile. The infants of the Group A will be fed with continuous nutrition until the achievement of
full enteral feeding. The infants of the Group B will be fed by bolus until the achievement of full enteral feeding.
Discussion: Evaluations of intestinal oximetry and superior mesenteric artery blood flow after the feed may help in
differentiating how the feeding regimen alters the splanchnic blood flow and oxygenation and if the changes
induced by feeding are different in IUGR versus NON IUGR infants.
Trial registration number: NCT01341236
Keywords: Feeding tolerance, Near infrared spectroscopy, Minimal enteral feeding, Enteral nutrition, Parenteral
nutrition, Intra-uterine growth restriction, Near infrared spectroscopy, Mesenteric artery Doppler, Bolus nutrition,
Intermittent nutritionBackground
Intra-uterine growth restriction (IUGR) caused by pla-
cental insufficiency is characterized by blood flow redis-
tribution to the vital organs (brain, myocardium, and
adrenal glands), while other organs, including the gastro-
intestinal tract, are deprived from sufficient blood flow.
As a consequence of gut ischemia/hypoxia, IUGR infants
are thought to have impaired gut function after birth,
which may result in intestinal disturbances, ranging
from temporary intolerance to the enteral feeding to
full-blown NEC.
In literature, however, there is no consensus regarding
the impact of enteral feeding on intestinal blood flow
and hence regarding the best regimen and the best rate
of delivering the enteral nutrition.
Doppler ultrasonography is the method currently used
for the clinical assessment of velocity of superior mesen-
teric artery blood flow [1]. Blood flows parameters in the
superior mesenteric artery (SMA) change with vasocon-
striction or vasodilatation of the intestinal vascular bed.
Prenatal utero-placental insufficiency with chronic fetal
hypoxia can lead to foetal growth retardation with a re-
distribution of blood flow favouring the cerebral circula-
tion and reducing mesenteric perfusion [2]. This
underlines the importance of chronic or acute hypoxia
as the most intensively studied condition associated with
disturbances of intestinal motility.
The possible association between the increase in blood
flow velocity and change in tissue oxygenation is
expected. Greater understanding of the rate of oxygen
delivery and uptake in sick preterm infants undergoing
intensive care is an important aim of neonatal medicine.
The assessment of adequate perfusion in very low
birth weight infants is commonly based on clinical para-
meters, as well as invasive measures requiring centralvenous and/or arterial catheter access with well estab-
lished associated risks. Additionally, most of these data
are acquired intermittently, and thus may only represent
a delayed picture of oxygen delivery and consumption.
Near-infrared spectroscopy (NIRS) is a continuous,
non-invasive, real-time and portable techinique, which
can be used to measure oxygenation in living tissue [3].
In 1985, Brazy and Lewis [4] reported the first
pediatric application of NIRS monitoring of cerebral
oxygenation in sick preterm infants. Since then the list
of publications on NIRS for hemodynamic and oxygen-
ation assessment in children and adults has rapidly
expanded [5,6].
The technological background of NIRS technology
has been reviewed in detail [7]. The main principle
upon which NIRS device relies is the fact that most
biological tissues, other than haemoglobin and cyto-
chrome oxidase, are relatively transparent to infrared
light in the range closest to the visual spectrum (700–
1000 nanometers), and that the absorbance spectrum of
the haemoglobin depends on its oxygenation status
(deoxygenated haemoglobin absorbs more red light and
less infrared light than oxygenated haemoglobin). All
devices emit lights at wavelengths within the above
mentioned spectrum and analyze photons returning to
the transducer. Because the change in the intensity of
the reflected light is dependent upon the oxyhemoglo-
bin to deoxyhemoglobin ratio, oxyhemoglobin satur-
ation can be derived [8]. There are many different
NIRS devices available. We use the INVOS cerebral ox-
imeter (Somanetics Corporation, Troy, Michigan USA)
that is FDA approved for adult and pediatric use in-
cluding infants [9].
NIRS has been used to monitor oxygenation of the
brain in neonates by measuring the ratio of oxygenated
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ation index”, TOI) [10]. NIRS has been reported to be
useful in detecting changes in splanchnic oxygen deliv-
ery and predicting splanchnic ischemia in neonates by
measuring the ratio of splanchnic to cerebral TOI, the
cerebrosplanchnic oxygenation ratio (CSOR). Splanchnic
oxygenation is compared with brain oxygenation as a
reference, because under most of physiological condi-
tions cerebral blood flow autoregulation minimizes
changes in brain oxygenation during events affecting
splanchnic perfusion [11].
A significant concern with the application of NIRS to
the abdomen is the possibility of movement of the gut
within the abdomen and also movement produced by
peristalsis of the gut wall. These two movements can
alter the scattering path of the near infrared light, result-
ing in absorption changes, which would swamp the sig-
nal of interest [12,13]. However TOI now offers a
method of comparing the haemoglobin redox status
within the splanchnic circulation, which is not path-
length-dependent because it provides a simultaneous
ratio of oxyhaemoglobin to deoxyhaemoglobin. Finally,
by measuring the TOI of the brain, which is preferen-
tially autoregulated with the splanchnic region under
most physiological conditions, the resultant CSOR ratio
gives absolute values, which allow comparison between
individual patients. CSOR had a 90% (56-100%) sensitiv-
ity to detect splanchnic ischaemia in neonates [14].
Regional tissue oxygenation of some other vascular
beds and its clinical relevance is under review in ex-
tremely low birth weight infants [15].
In an effort to decrease the risk for development of
NEC in preterm infants, enteral nutrition is often
delayed when the neonate shows signs of feeding in-
tolerance. However, enteral fasting can predispose a
neonate to impaired intestinal growth, mucosal atro-
phy, intestinal barrier dysfunction, decreased digestive
and absorptive capacity, increased colonization with
pathogenic bacteria, and systemic inflammation. In
addition, enteral fasting can prolong the time to estab-
lish full enteral feeding and the length of hospital stay
[16]. Consequently, minimal enteral feeding (MEF) in
combination with parenteral nutrition (PN) is often
employed to alleviate the side effects of enteral fasting
in premature infants. MEF is thought to promote in-
testinal motility, to maintain the intestinal barrier, to
stimulate the development of “good” microflora, and
to reduce infections.
Tube feeding is necessary for most premature infants
less than 1500 grams because of their inability to co-
ordinate sucking, swallowing, and breathing and the
risk of aspiration. The conventional tube feeding
method is intermittent bolus gavage feeding, where a
prescribed volume of milk is given over a short periodof time, usually over 10 to 20 minutes by gravity. Some
clinicians prefer the continuous nasogastric route to
feed premature infants less than 1500 grams birth
weight, although, in practice, intermittent bolus gavage
feeding is the method more commonly used [17,18]. In
our Unit VLBW infants are fed by boluses, although
they are often empirically switched to the continuous
infusion method without an established rationale. The-
oretical risks and benefits of both continuous nasogas-
tric milk feeding and intermittent bolus milk feeding
have been proposed. Continuous nasogastric feedings
may improve energy efficiency (by increasing energy
absorbed and decreasing energy expenditure), reduce
feeding intolerance, improve nutrient absorption, and
improve growth. However, continuous infusion of milk
into the gastrointestinal tract could alter the cyclical
pattern of release of gastrointestinal tract hormones,
which might affect metabolic homeostasis, and growth.
Milk feedings given by bolus gavage method are
thought to be more physiologic because they promote
the cyclical surges of gastrointestinal tract hormones
normally seen in healthy term infants. On the other
hand, functional limitations of the premature infant’s
gastrointestinal system such as delayed gastric emptying
or intestinal transit could hinder the premature infant’s
ability to handle bolus milk feeds, resulting in feeding
intolerance.
Additionally, this feeding regimen that alternates be-
tween periods of feeding and fasting may challenge the
premature infant’s ability to maintain metabolic homeo-
stasis and, therefore, decrease growth. There is still a de-
bate about which is the best feeding regimen in order to
prevent episodes of feeding intolerance and to promote
a better growth.
Aims of the study
Primary aim of this study:
1. To evaluate the changes in the intestinal perfusion
and oximetry determined by feeding in VLBW
infants fed by 3 hours nasogastric nutrition (CN)
versus infants fed by bolus nutrition (BN).
Secondary aims of the study:
2. To compare if changes in the intestinal perfusion
and oximetry induced by feeding are different
between IUGR and NON-IUGR infants.
3. To compare growth and nutritional status of the 2
groups by randomized arm.
4. To test if changes in intestinal oximetry and
perfusion can be reliable predictors of feeding
intolerance (days necessary to achieve full enteral
feeding).
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The endpoint for the primary aim will be the cross-over
difference of CSOR values, measured with NIRS before
and at the end of the randomized feeds.
Aims 1 to 4 will be pursued analysing the following
endpoints:
 The cross-over difference of CSOR values and of
rSO2s values (i.e. the splanchnic saturation slope) in
IUGR and non-IUGR infants.
 Growth and nutritional status will be measured
by weight, length and head circumference. Main
comparison will be between measures at
randomization and at achievement of full enteral
feeding. The growth at 28 days of life and at
36 weeks of gestational age will also be compared
with the appropriate standard growth curves.
 The difference in the CSOR values pre- and
post- feeding will be compared with the baseline
CSOR value and the baseline Doppler flow
velocimetry (both measured within the first 72
hours of life).
 Comparison of the time needed to reach full enteral
feeding (i.e. days from randomization till enteral
intake of 160 ml/kg/day of formula or fortified
human milk) by randomized arm;
Methods and design
This is a randomized, non-pharmacological, single-
center, cross-over study. Duration of the study:
24 months. The study takes place in the Neonatal In-
tensive Care Unit.
This study aims at recruiting about twenty very low
birth weight infants, either IUGR or NON-IUGR.
Inclusion criteria
 Weight at birth ranging: 700–1501 grams;
 Gestational age up to 25 weeks and 6 days;
 Written informed consent from parents or
guardians.
Exclusion criteria
 Major congenital abnormalities (severe heart or
cerebral disease, chromosomopathies, severe renal
malformations, any malformation or disease of the
gastroenteric tract)
 Patients enrolled in other trials
 Significant multi-organ failure prior to trial entry
(perinatal asphyxia with renal, cardiac or cerebral
impairment, DIC)
 Pre-existing cutaneous disease not allowing the
placement of the probeEligibility to randomization
Infants who fulfill the following requirements are eligible
to randomization:
 achievement of at least 100 mL/Kg/day of enteral
nutrition
 adequate ventilation i.e. infants who are not
intubated and not in-cPAP with a FiO2≥50% at the
achievement of 100 mL/Kg/day of enteral nutrition;
 no NEC;
 Written informed consent from parents or
guardians.
Stratification
Randomization will be stratified in two groups: IUGR
infants (approximately 10 children) and NON-IUGR
infants (approximately 10 children).
At the achievement of an enteral intake of 100 mL/
Kg/day the patients (IUGR and NON IUGR separately)
will be randomized in 2 groups: Group A (n=10) will
start with bolus administration of nutrition (in 10 min-
utes); then, after at least 3 hours, they will be fed by the
same amount of feed administered as continuous nutri-
tion for 3 hours; Group B (n=10) will start with continu-
ous administration of nutrition for 3 hours followed by a
bolus administration of the same amount of feed (in 10
minutes) after at least 3 hours.
The infants of the Group A will be fed with continu-
ous nutrition until the achievement of full enteral feed-
ing (enteral intake of 160 mL/Kg). The infants of the
Group B will be fed with 7 or 8 boli/d until the achieve-
ment of full enteral feeding.
If, due to clinical instability (i.e. desaturation episodes
or bradicardia) during the feeding, a change occurs in
the modality of feeding, the results will be analyzed
according to the “intention to treat” or the “by treat-
ment” analysis.
All the patients will undergo a baseline evaluation in
the first 72 hours of life including: cerebral ultrasound,
cardiac ultrasound and abdominal ultrasound.
After birth, in the first 24 hours of life, and in the transi-
tional period, between the 48th and 72nd hours of life, all
infants’ intestinal perfusion will be evaluated with NIRS
and the echocolordoppler (evaluation of the superior mes-
enteric artery blood flow) will be performed. The evalua-
tions with NIRS and with the echocolordoppler will be
performed under condition of clinical stability (absence of
arterial desaturation or instability of cardiocirculatory
parameters). Data from NIRS will be collected for 3 hours.
Other anamnestic and clinical data will be collected
(gestational age, umbilical arterial pH, race, obstetrical an-
amnesis, mode of delivery, umbilical arterial and venous
catheters, patent ductus arteriosus, respiratory distress
syndrome, mechanical ventilation, episodes of clinical
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the moment of the first two evaluations.
According to our protocol enteral nutrition will start
after the 72nd hour of life as minimal enteral feeding
(MEF), intake less than 20 mL/Kg/day of enteral feeding
will be administered. The increase will be by 20 mL/Kg/
day if enteral nutrition is well tolerated. All the infants,
according to our standardized protocol, will start paren-
teral nutrition on the first day of life. The infants will be
fed with human milk, if available, (human milk will be
fortified at an achievement of an enteral intake of
100 ml/Kg/d), or with a preterm formula (75–80 Kcal/
100 mL). The nutrition will be administered via the
nasogastric route.
On the randomization day intestinal and cerebral re-
gional oximetry will be measured via near infrared spec-
troscopy (NIRS) (INVOS- 5100 C) sensors placed over
the abdomen (splanchnic bed) and on the forehead
(cerebral bed). Recording of the tissues oximetry will
start 30 minutes before the feed and will stop 30 min-
utes after the end of the nutrition. Intestinal and celebral
oximetry will be measured before the feed (B0) and 30
minutes after the feed (B1) by bolus; during the continu-
ous nutrition the measurements will be performed be-
fore (C0), 30 minutes from the start of the nutrition (C1)
and 30 minutes after the end of the gavage (C2).
The TOI will be obtained simultaneously at the two
locations. The TOI measurement recordings will be
obtained for 3 minutes from both the head and the abdo-
men. Those measurements will be combined as a ratio
of abdominal TOI over brain TOI to produce a CSOR
(TOIabdomen/TOIbrain). Arterial haemoglobin oxygen sat-
uration, measured by pulse oximetry, will be recorded
during the NIRS tracing. NIRS tracing will be used
only in the absence of desaturation (< 85% arterial
saturation).
Capillar haemoglobin concentration will be measured
on the day of the evaluation.
An evaluation of blood flow velocity of the superior
mesenteric artery (peak sistolic and end-diastolic velocity,
mean velocity, and pulsatility index) will be performed
meanwhile. To achieve imaging of the SMA the transducer
will be placed on the mid-abdomen above the umbilicus.
The SMA will be identified at its emergency from the
aorta and sample volume will be placed a few millimetres
from its origin. Neonatologists with the same expertise
and manual ability will perform the ecocholordoppler eva-
luations. The evaluations and the measurements will be
performed on 5 contiguous homogeneous waves.
Measurements of body weight, length and head cir-
cumference will be performed at predefined times: at
birth, at the beginning of MEF, on the randomization
day, at the achievement of full enteral feeding, at 28 days
of life and at 36 weeks of gestational age.Parameters of feeding tolerance are those routinary
used in the NICU (maximum gastric residual and re-
sidual appearance). The enteral nutrition will be discon-
tinued or carried on according to our feeding protocol.
The follow-up will end at the achievement of a full en-
teral feeding, enteral intake of 160 mL/Kg/die or at
28 days of life, whichever occurs later. Patients may
drop-out before this intended end because of the follow-
ing withdrawal causes:
– Withdrawal of the consent by the relatives
– Severe skin reaction due to the skin probe
– Transferral to another hospital
– Death
After study end, patients will be fed according to the
standard protocol of our Unit.
During the study, recommended diagnostic and thera-
peutic procedures are those usually performed as stand-
ard care in our Unit.
No new special measure for safety is planned since all
the diagnostic and therapeutic procedures are part of the
standard approach to the VLBW infant in our Unit.
Statistical considerations
Randomization
Randomized interventions are described in Section
‘Methods and Design’. This section summarizes proce-
dures and methodology, which will be adopted.
Patients eligible to randomization: all VLBW infants
enrolled and eligible to the study, either IUGR or non-
IUGR, who fulfil the following requirements:
1. achievement of 100 mL/kg/day of enteral nutrition;
2. adequate ventilation i.e. infants who are not
intubated and not in-cPAP with a FiO2≥50% at the
achievement of 100 mL/Kg/day of enteral nutrition;
3. no NEC;
4. Informed consent from parents or guardians.
When to randomize:
a. After achievement of 100 mL/kg/day of enteral
nutrition in presence of adequate ventilation (see
point 2 above)
Modalities of randomization:
b. Logistics: investigators will ask for randomization by
access to a specific software which will provide the
assigned arm, after check on the eligibility criteria.
c. Methodology: randomization will be stratified (IUGR
vs non-IUGR) and by blocks: the random
assignment will be produced by an automatic
Table 1 Impact on CSOR under BN=0.10
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permuted blocks of small size, given the limited
number of infants expected in each stratum.
Randomization refusals: if parents or guardians do
not agree with randomization, patients will be excluded
from the study and should be fed according to nutrition
procedure regarded as the most appropriate for the child
based on the Unit standard policy.
Statistical analysis
The primary aim of the study is to compare the impact
on intestinal perfusion of 2 different nutrition modal-
ities, bolus (BN, Group A) versus a 3-hour nasogastric
nutrition (CN, Group B). The impact on intestinal perfu-
sion is defined as the difference between pre- and post-
prandial CSOR values measured with NIRS 30 minutes
before feeding and at the expected peak after feeding
(3 hours in CN and 30 minutes in BN). Pre- and post-
prandial CSOR values will be calculated as the mean of
5-minute NIRS evaluations about the intended time-
point (e.g. for baseline CSOR measurement, 2.5 minutes
before and 2.5 minutes after the 30th minute before start
of the randomized feed). Given that the study is a cross-
over study, each infant will be evaluated both for CN
and BN and the cross-over CSOR difference will be the
primary endpoint.
As a secondary analysis, the cross-over difference of
CSOR values as well as that of SO2s values (i.e. the
splanchnic saturation slope) will be analysed comparing
intra-uterine growth (IUGR vs. non-IUGR).
The impact of the 2 nutrition modalities on CSOR will
also be studied in a multivariable context, adjusting for
factors including the baseline CSOR value, the baseline
Doppler flow velocimetry (both measured within the
first 72 hours of life) and the intra-uterine growth (IUGR
vs. non-IUGR).
Other secondary analyses include:
 Comparison of the time needed to reach full enteral
feeding (i.e. days from randomization till enteral
intake of 160 mL/Kg/day of formula or human milk)
by randomized arm;
 Comparison of growth as measured by weight,
length and head circumference by randomized arm.
Main comparison will be between measures at
randomization and at achievement of full enteral
feeding. The growth at 28 days of life will also be
compared with the appropriate standard growth
curves.
The primary end-point analysis as well as all secondary
analyses regarding randomized patients will be based on
the ITT (intention-to-treat) principle. Comparisons ofthe two arms accounting for deviations from the
assigned arm (analyses by “performed treatment”) will
also be added to this main analysis. The primary end-
point will be analyzed with a two-tailed matched pairs
t-test, after checking of appropriateness of assumptions.
In particular, checking will concern the normality
assumption, since period effect and cross-over effect ap-
pear both very unlikely in this study. Should normality
be not adequate, non-parametric test such as the Wil-
coxon signed ranks test will be applied [20]. An appro-
priate generalized linear model will be used to
investigate the relationship between the CSOR cross-
over difference and the candidate covariates. Should any
raw CSOR observations be missing (e.g. NIRS instru-
ment failed to measure or to save measurements), their
estimation via imputation or other appropriate methods
will be taken into account. The comparison of growth
variables by randomized arm will be performed with ei-
ther the two-tailed t-test or a non-parametric alternative
(e.g. Mann–Whitney test), should the normality assump-
tion be not reasonable. The time from randomization till
achievement of the full enteral feeding will be analysed
with the Kaplan-Meier estimator, in which full enteral
feeding as defined in the protocol will be considered as
the sole ‘event’, while censoring will occur for withdrawal
for any cause. Standard errors will be computed accord-
ing to Greenwood formula and the log-rank test will be
used for univariate comparisons.
Sample size
This single-center study will recruit patients for 2 years
(24 months) since official opening. The expected accrual
is about 20 VLBW infants, either IUGR or non-IUGR.
The power calculations below are based on a two-tailed
t-test with I-type error α=0.05 and show the power that
the 20-patient study will achieve under various differ-
ences in CSOR from the ‘baseline’ impact observed
under BN. On the basis of previous studies [21] this is
expected to be 0.10 (mean of CSOR pre-post prandial
difference), while various hypothesis are made about its
standard deviation, σCSOR
Sample size: 20 infants
The power calculations in different scenarios show that
with 20 patients the study will achieve a good power in
presence of a cross-over difference of at least 0.07
(Table 1).
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The case report form (CRF) attached to the protocol
describes the data needed for each patient (see Additional
file 1). A specific database will be set up which will capture
the data produced by the NIRS instrument and automatic-
ally saved in an exportable file and the demographic and
clinical data routinely available in the electronic clinical
chart used by the center. Other variables, collected ad hoc
for this study, will be entered in the same database by the
Trial Data Center.
Discussion
This is an explorative study. Evaluations of intestinal ox-
imetry and superior mesenteric artery blood flow after
the feed may help in differentiating how the feeding regi-
men alters the splanchnic blood flow and oxygenation
and if the changes induced by feeding are different in
IUGR versus NON IUGR infants.
We postulate that TOI will be altered in the vascular
bed when blood flow is decreased; the resultant acidosis
in poorly perfused tissues may also further increase the
dissociation of oxygen from haemoglobin and increase
the portion of reduced haemoglobin detected with NIRS.
This condition may be present in IUGR infants and this
condition may alter feeding tolerance thus requiring a
longer time to achieve full enteral feeding and increasing
the episodes of feeding intolerance.
Gut perfusion may depend on the way of administer-
ing feeding, bolus or continuous nutrition, so this study
may suggest which is the best way to feed VLBW
infants.
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